Why OM1 is Different & Meet our AI Expert

Why We're Different

OM1 is led by clinical experts. Identifying patients using data and technology, with their oversight, is what we do best.

We focus on specific applications where we excel. We don’t throw AI at everything – we’re precise in the questions we tackle.

We’ve built PhenOM on our industry-leading datasets. We have enough data – in volume and quality – to excel in our focus areas.

We can deliver PhenOM modules into clinical settings covering over 60% of the US population. If there’s a condition or treatment where screening could help, get in touch!

Meet Our AI Expert

Joseph Zabinski, PhD, MEM is Managing Director, AI & Personalized Medicine at OM1, where he oversees development and deployment of AI products across a range of use cases in partnership with pharmaceutical and medical device companies, providers, and health plans.

Prior to joining OM1, Dr. Zabinski was a consultant in the Pharmaceutical and Medical Products Practice at McKinsey & Co. He specialized in advising life science and healthcare clients on using AI and advanced analytics, including identification of unmet medical needs, portfolio optimization, and AI strategy.

His academic research focused on applications of Bayesian network modeling methods to predicting and stratifying environmental human health risk. Dr. Zabinski holds a master’s degree in engineering management from Dartmouth College, and a doctorate with a focus in health analytics from the School of Public Health at the University of North Carolina, Chapel Hill.

Joe is a 2023 Healthcare Innovation 40 Under 40 Winner.

Overall, how would you describe your understanding of AI in healthcare before reading this e-book?

Beginner
Intermediate
Advanced

Do you feel the e-book effectively communicates the unique aspects of PhenOM® in comparison to other AI healthcare solutions?

Yes
Somewhat
Neutral
Not Really
No